September 3, 2019 | Lao Tribune

Daily Archives September 3, 2019

Taconic Biosciences Participates in Second Rodent Research Reference ...

Resulting Studies Will Provide Critical Reference Data to Drive Advancements in Human Health RENSSELAER, N.Y., Sept. 03, 2019 (GLOBE NEWSWIRE) — Taconic Biosciences, a global leader in providing genetically engineered animal model solutions, announces its participation in the second Rodent Research Reference mission to the International Space Station. Taconic has a history with NASA dating […]Read More

Teledyne e2v announces new CMOS Sensor Family, targeted at 3D Laser ...

Teledyne e2v/CMOS sensor family GRENOBLE, France, Sept. 03, 2019 (GLOBE NEWSWIRE) — Teledyne e2v, a Teledyne Technologies [NYSE: TDY] company and global innovator of imaging solutions, announces its Flash CMOS image sensor family, specifically tailored for 3D laser profiling/displacement applications and high speed, high resolution inspection. The new Flash sensors feature a 6μm CMOS global […]Read More

A view into SNOMED CT’s globally recognized clinical terminology ...

London, United Kingdom, Sept. 03, 2019 (GLOBE NEWSWIRE) — Picture an elderly patient navigating orthopaedic care across primary, acute and rehabilitative sectors; a woman moving through breast cancer diagnosis and treatment in a developing digital health environment; or gathering critical patient information in the midst of a conflict, epidemic or disaster. These scenarios represent instances […]Read More

Batavia Biosciences to deploy Horizon Discovery’s CHO cell ...

Leiden, 3 September 2019 – Today, Batavia Biosciences announced that the company has signed a license agreement to utilize Horizon Discovery’s GS knockout CHO K1 cell line expression system for the development of high yield antibody-expressing cell lines. Initially, Batavia will deploy the system for production of a potent Zika virus neutralizing antibody, working in collaboration […]Read More

Allecra Therapeutics to Present Data at ASM/ESCMID 2019 Conference on ...

LÖRRACH, Germany and SAINT-LOUIS, France, Sept. 03, 2019 (GLOBE NEWSWIRE) — Allecra Therapeutics (Private), a biopharmaceutical company focused on developing and commercializing novel antibiotics to treat life-threatening multidrug-resistant infections, today announced four upcoming presentations at the ASM/ESCMID 2019 Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance, taking place September 3-6 in Boston, […]Read More